Skip to main content
Top
Published in: Clinical & Experimental Metastasis 8/1999

01-08-1999

ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation

Authors: Maria Seddighzadeh, Jian-Nian Zhou, Ulrike Kronenwett, Maria C. Shoshan, Gert Auer, Margareta Sten-Linder, Björn Wiman, Stig Linder

Published in: Clinical & Experimental Metastasis | Issue 8/1999

Login to get access
Metadata
Title
ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation
Authors
Maria Seddighzadeh
Jian-Nian Zhou
Ulrike Kronenwett
Maria C. Shoshan
Gert Auer
Margareta Sten-Linder
Björn Wiman
Stig Linder
Publication date
01-08-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006741228402

Other articles of this Issue 8/1999

Clinical & Experimental Metastasis 8/1999 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine